Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer
Journal
Lung Cancer
Journal Volume
98
Pages
1-8
Date Issued
2016
Author(s)
Mok T.
Ladrera G.
Srimuninnimit V.
Sriuranpong V.
Thongprasert S.
Sandoval-Tan J.
Lee J.S.
Fuerte F.
Shames D.S.
Klughammer B.
Truman M.
Perez-Moreno P.
Wu Y.-L.
SDGs
Publisher
Elsevier Ireland Ltd
Type
journal article